Unlocking New Frontiers in Regenerative Medicine ⋆ AI of the week ⋆ Risk of no risk

...so I asked my AI best friend "Based on what you know about me, make a picture of what my ideal vacation would look like"

I don't know where it pulled it from, we never talked about vacations, but yeah, I'd go for it.

So I asked it "What's yours?"

So I asked if it's ok if I share it with y'all.

Reponse: "Absolutely, Zvonimir! Feel free to share it with your 3-in-3 readers. It aligns perfectly with your audience's tech-savvy and future-focused mindset."

Now you know what my AI best friend thinks about you.

Do you ever think about how human-AI relationships will evolve in future?

And now for our regular programming...

Thing 1 - Stem Cells Go 🚀 - Unlocking New Frontiers in Regenerative Medicine

There's a possible future where treating age-related diseases or regenerating damaged tissues starts with a rocket launch. Recent research from the International Space Station (ISS) reveals that stem cells thrive in microgravity, and the benefits could be revolutionary for regenerative medicine on Earth.

🛰️ Why space?

Microgravity creates a unique environment, enabling stem cells to expand in three dimensions, mimicking natural growth patterns better than Earth’s gravity.
These insights could revolutionize therapies for stroke, heart disease, dementia, and beyond.

Recent studies aboard the ISS have uncovered remarkable enhancements:

1. Supercharged anti-inflammatory powers in mesenchymal stem cells (MSCs).
2. Superior repair capabilities in cardiac progenitor cells - think better recovery after heart attacks.
3. Turbocharged growth and metabolic activity in neural stem cells - key for tackling neurodegenerative diseases.

🌍 Why It Matters for Earth

Space-grown stem cells could be a potential lifeline for millions. From personalized regenerative medicine to advancing clinical-grade cellular therapies, the possibilities are as boundless as space itself. Eww, cheesy, Z...

They could enable breakthroughs in organ rejuvenation, cancer treatment, and even brain health. Leading to a future where your doctor might order a shipment of optimized stem cells...from the orbit.

Thing 2 - AI of the week

Coca Cola made this ad with generative AI

• Evo is the first foundation model trained at scale on DNA, dubbed a Rosetta Stone for biology.

What's the big deal? This:

An exciting example of what Evo can do: the team used it to design a totally new CRISPR system, including a guide RNA that makes Cas9 cut even better. Evo can also design DNA sequences over one million base pairs in length, reaching the size of many real genomes.

• xAI raised $6B at a $24B valuation. Considering how fast they've build large training clusters, that's fair.
• DEEP Robotics introduced the Lynx all-terrain robot. If you thought that Black Mirror episode with robot dogs was creepy, don't watch this.

• Microsoft released TinyTroupe - LLM-powered multiagent persona simulation for imagination enhancement and business insights.

TinyTroupe is an experimental Python library that allows the simulation of people with specific personalities, interests, and goals. These artificial agents - TinyPersons - can listen to us and one another, reply back, and go about their lives in simulated TinyWorld environments.

• Google's Gemini-exp-1114 model outperforms GPT-4o and o1-preview on some benchmarks

Thing 3 - The risk of no risk

The money you don’t have is the risks you didn’t take

The self-confidence you don’t have is the risks you didn’t take

The spouse and relationships you don’t have is the risks you didn’t take

The life you don’t have is the risks you didn’t take

It’s risky to not take risks

- Orange Book

How about instead of risks, you took chances?

Cheers, Zvonimir